These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 659429)

  • 21. Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.
    Yu L; Martins A; Deng L; Shuman S
    J Virol; 1997 Dec; 71(12):9837-43. PubMed ID: 9371657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of vaccinia from heat inactivation by nucleotide triphosphates.
    Munyon W; Mann J; Grace JT
    J Virol; 1970 Jan; 5(1):32-8. PubMed ID: 4315159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of the 5'-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus.
    Ensinger MJ; Martin SA; Paoletti E; Moss B
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2525-9. PubMed ID: 1058472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of the 5'-terminals of mRNAs by viral and cellular enzymes.
    Moss B; Martin SA; Ensinger MJ; Boone RF; Wei CM
    Prog Nucleic Acid Res Mol Biol; 1976; 19():63-81. PubMed ID: 798242
    [No Abstract]   [Full Text] [Related]  

  • 25. Domain structure of vaccinia virus mRNA capping enzyme. Activity of the Mr 95,000 subunit expressed in Escherichia coli.
    Shuman S; Morham SG
    J Biol Chem; 1990 Jul; 265(20):11967-72. PubMed ID: 2164023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinia virus poly(A) polymerase. Specificity for nucleotides and nucleotide analogs.
    Shuman S; Moss B
    J Biol Chem; 1988 Jun; 263(17):8405-12. PubMed ID: 2836422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the vaccinia virus RNA 5'-triphosphatase and nucleotide triphosphate phosphohydrolase activities. Demonstrate that both activities are carried out at the same active site.
    Myette JR; Niles EG
    J Biol Chem; 1996 May; 271(20):11945-52. PubMed ID: 8662636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA polymerase activity in purified infectious vaccinia virus.
    Munyon W; Paoletti E; Grace JT
    Proc Natl Acad Sci U S A; 1967 Dec; 58(6):2280-7. PubMed ID: 5242206
    [No Abstract]   [Full Text] [Related]  

  • 29. Methyltransferase and subunit association domains of vaccinia virus mRNA capping enzyme.
    Cong P; Shuman S
    J Biol Chem; 1992 Aug; 267(23):16424-9. PubMed ID: 1322901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of the guanylylated and methylated 5'-terminus of vaccinia virus mRNA.
    Moss B; Gershowitz A; Wei CM; Boone R
    Virology; 1976 Jul; 72(2):341-51. PubMed ID: 948865
    [No Abstract]   [Full Text] [Related]  

  • 31. Methylation of 5'-5' confronting dinucleotides by vaccinia associated enzyme system.
    Urushibara T; Okamoto T; Nishimura C; Kamimura T; Osaki Y; Yamaguchi K; Hata T; Miura K
    Nucleic Acids Symp Ser; 1981; (10):237-40. PubMed ID: 6273829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA 5'-triphosphatase, nucleoside triphosphatase, and guanylyltransferase activities of baculovirus LEF-4 protein.
    Gross CH; Shuman S
    J Virol; 1998 Dec; 72(12):10020-8. PubMed ID: 9811740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Messenger RNA guanylyltransferase from Saccharomyces cerevisiae. Large scale purification, subunit functions, and subcellular localization.
    Itoh N; Yamada H; Kaziro Y; Mizumoto K
    J Biol Chem; 1987 Feb; 262(5):1989-95. PubMed ID: 3029058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and enzymatic characterization of protein lambda 2, the reovirus guanylyltransferase.
    Mao ZX; Joklik WK
    Virology; 1991 Nov; 185(1):377-86. PubMed ID: 1656591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elongation properties of vaccinia virus RNA polymerase: pausing, slippage, 3' end addition, and termination site choice.
    Deng L; Shuman S
    Biochemistry; 1997 Dec; 36(50):15892-9. PubMed ID: 9398322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA capping by HeLa cell RNA guanylyltransferase. Characterization of a covalent protein-guanylate intermediate.
    Shuman S
    J Biol Chem; 1982 Jun; 257(12):7237-45. PubMed ID: 6282835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of S-adenosylhomocysteine analogues on vaccinia viral messenger ribonucleic acid synthesis and methylation.
    Pugh CS; Borchardt RT
    Biochemistry; 1982 Mar; 21(7):1535-41. PubMed ID: 6282307
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism of the mRNA guanylyltransferase reaction: isolation of N epsilon-phospholysine and GMP (5' leads to N epsilon) lysine from the guanylyl-enzyme intermediate.
    Toyama R; Mizumoto K; Nakahara Y; Tatsuno T; Kaziro Y
    EMBO J; 1983; 2(12):2195-201. PubMed ID: 6321153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide phosphohydrolase in purified vaccinia virus.
    Munyon W; Paoletti E; Ospina J; Grace JT
    J Virol; 1968 Mar; 2(3):167-72. PubMed ID: 4986904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping the active site of vaccinia virus RNA triphosphatase.
    Gong C; Shuman S
    Virology; 2003 Apr; 309(1):125-34. PubMed ID: 12726733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.